Thanks for joining DividendStocks.com, the daily newsletter built for dividend and income investors like you. We’re thrilled to have you on board and can’t wait to help you discover the best dividend opportunities out there. Before we can start sending your daily insights, please take a quick moment to confirm your subscription: Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Why wait? Let’s get your dividend journey started! Click Here to Start Discovering Top Income-Generating Stocks See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Further Reading from MarketBeat Media Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025Submitted by Leo Miller. First Published: 1/3/2026. 
In Brief - While small caps as a whole generated lower returns than large caps in 2025, three interesting names bucked this narrative.
- A cancer screening company and two satellite operators saw their shares rise 300% or more.
- See where analysts are forecasting upside and understand vital considerations pertaining to smaller stocks.
In 2025, small-cap stocks broadly lagged. The Russell 2000 Index, which tracks 2,000 U.S. small-cap companies, returned roughly 13% for the year—well below the S&P 500 Index's total return of about 18%, which tracks U.S. large-cap stocks. Still, three small-cap names delivered exceptional gains in 2025. Below are three stocks that rose more than 300% during the year. Each began 2025 in small-cap territory but, after their rallies, has since moved into mid-cap range. GRAL Catapults on Early Cancer Detection Enthusiasm Gold Headed Above $5,000 per Ounce in 2026? Here's How to Play It...
With so many strange events happening across the economy (consumer confidence plummeting, credit-card delinquencies soaring, and more), it's no wonder the richest investors are loading up on gold. But what you might not realize is that there's a much better way to profit from rising gold prices - WITHOUT ever touching an ETF, mining stock, or even bullion. Get the full details here. Healthcare stock GRAIL (NASDAQ: GRAL) climbed roughly 380% in 2025, pushing its market capitalization from well under $1 billion to about $3.3 billion. GRAIL's flagship product is the Galleri multi-cancer early-detection test. Early detection substantially improves survival rates, which has driven considerable interest in Galleri. Only about five cancer types have standardized screening methods, yet roughly 70% of cancer deaths come from other cancers. Galleri is designed to detect more than 50 cancer types. In a recent study, GRAIL reported that adding Galleri to traditional screening increased early cancer detection by more than seven times. Today most Galleri revenue comes from out-of-pocket payments, but GRAIL expects to submit a Premarket Approval (PMA) application to the U.S. Food and Drug Administration in the first quarter of 2026. If approved, commercial insurers would be far more likely to cover the test, opening a material new sales channel—which helps explain investor enthusiasm. The MarketBeat consensus price target of $97.50 reflects analyst optimism and implies roughly 14% upside from current levels. PL Blasts Off, Combining AI with Geospatial Imagery Planet Labs PBC (NYSE: PL) enjoyed a huge 2025, with shares up just under 390%. Planet operates a constellation of satellites that collect medium- to high-resolution Earth imagery and pairs that data with artificial intelligence to help customers make decisions. The company sells subscriptions to its cloud-based platform and satellite services. Demand is materializing, particularly among government clients. Its Dec. 10 earnings report sent shares up 35% in one day, driven by defense and intelligence revenue rising more than 70%. Planet also reported a backlog of about $735 million—roughly 2.6 times its last 12 months' revenue of $282 million—providing scope for meaningful growth. The company also produced positive free cash flow for a second consecutive quarter. The MarketBeat consensus price target of $14.74 implies about 25% downside. However, analyst targets updated after the Dec. earnings report average $18.19, which would imply only about 7.7% downside. Planet Labs is worth watching—any significant pullback could present a more attractive entry point. Updated Targets Eye Strong Upside in VSAT After Huge 2025 Run Finally, Viasat (NASDAQ: VSAT) rose roughly 305% in 2025 and now has a market cap around $4.7 billion. Viasat is another satellite operator, focused on internet and data connectivity rather than consumer telecom. Its primary markets are aviation, maritime and government customers, making it distinct from peers such as AST SpaceMobile (NASDAQ: ASTS). Viasat provides in-flight connectivity to thousands of commercial and business aircraft. The U.S. government was Viasat's largest customer in fiscal 2025, accounting for 18% of revenue; the company is currently in fiscal 2026. Revenues grew only 2% last quarter, but bookings rose 17% to nearly $1.5 billion and the backlog climbed to almost $3.9 billion. The MarketBeat consensus price target of $32.75 implies about 5% downside. Analysts who updated targets after the Nov. 7 earnings report are more bullish: their average target is $49, suggesting roughly 37% upside. GRAL, PL, VSAT: Deep Research Is Paramount GRAL, PL and VSAT delivered extraordinary returns in 2025, but investors should remember that smaller-cap names—especially those that have run sharply—carry elevated risk and can be highly volatile. Confidence in a company's long-term outlook and thorough due diligence are essential before allocating capital to these stocks.
| 
